Victoria Reichl

Dr. Victoria Reichl is a researcher at the SALK Institute in the Department of Dermatology and Allergology. Her work focuses on molecular therapies for genodermatoses, particularly epidermolysis bullosa, combining RNA-based approaches and metabolic inhibition strategies.

• Recipient of the Clemens von Pirquet Prize (2009) from the Austrian Society of Allergology and Immunology (ÖGAI).
• Active in translational research, including RNA trans-splicing, COL17A1 reframing, and metabolic targeting in skin cancer.

Her recent publications highlight advancements in non-invasive RNA therapy and anti-neoplastic strategies for aggressive cutaneous squamous cell carcinoma associated with epidermolysis bullosa.

Scientific Awards:

• Clemens von Pirquet Prize (2009)

Current research involves collaborations with multidisciplinary teams in the Research Program of Molecular Therapy of Genodermatoses, focusing on gene editing, metabolic pathways, and clinical applications for rare skin diseases.